HETEROCYCLIC DERIVATIVES AS M3 MUSCARINIC RECEPTORS

摘要

This invention relates to M3 antagonists of formula (I) wherein R², R⁴, R⁵, R⁶, W, V, A, D, X, t, u and v are as defined herein; pharmaceutical compositions containing them; methods for their preparation; and their use in the treatment of diseases where enhanced M3 receptor activation is implicated.